Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy And Ecc Procedures) Market - Global Industry Analysis By Test Type And Age Group, Market Size, Share And Forecast, 2012 - 2018
NEW YORK, Oct. 31, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p01022402/Cervical-Cancer-Diagnostic-Tests-Pap-Smear-Colposcopy-And-Ecc-Procedures-Market---Global-Industry-Analysis-By-Test-Type-And-Age-Group-Market-Size-Share-And-Forecast-2012---2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
Description
This report covers an analysis for cervical cancer diagnostic tests (Pap smear tests, Colposcopy tests and ECC procedures) market. The market is analyzed in terms of number of test results and procedures performed in thousands and revenue in USD thousands. Pap smear testing is a cervical cancer diagnosis method performed on women. It is a preventive measure and is done to test for the presence of cervical cancer in an early stage. Cervical cancer, if detected at an early stage could be treated successfully. An abnormal Pap smear test result leads to the performance of further tests and procedures in order to confirm the presence of cervical cancer.
The cervical cancer diagnostic tests market is segmented on the basis of types into Pap smear tests, Colposcopy tests, and ECC procedures. The number of tests performed and its market revenue is forecasted in this report for Pap smear tests, Colposcopy tests and ECC procedures. The market is also segmented on the basis of geography into three regions namely the U.S, Europe and Asia Pacific. The European region is further segmented into six regions namely: U.K, Germany, Italy, France, Spain and the Rest of Europe. The Asia Pacific market is also sub segmented into three regions namely: India, China and Japan.
This report covers an in depth analysis of the players/companies that exist in the market. A detailed analysis of their business strategies, financial information, company overview, recent developments and SWOT is also included in the report. The market players considered are: Guided Therapeutics, Abott Laboratories, Siemens Healthcare, Ascon Medical Instruments, Olympus, Beckman Coulter Inc, Roche, Cooper Surgical Inc, Cardinal Health and Becton, Dickinson and Company.
We have used secondary research for deriving our market numbers for each segment of the research report and further validated our analysis with C-level executives of major companies operating in the cervical cancer diagnostic tests market through the means of primary research to finally come up with our results. This research is specially designed to estimate and analyze the performance in Pap smear testing in a global scenario. This research provides in-depth analysis of Pap smear testing market sales, trend analysis by segments and demand by geography.
The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the global Pap smear tests, Colposcopy tests and ECC procedures market as below:
Cervical Cancer Diagnostic Tests Market by Types
Pap Smear Tests
Abnormal Pap Smear Tests
Colposcopy Tests
Abnormal Colposcopy Tests
ECC Procedures
Cervical Cancer Diagnostic Tests Market by Age Group
Age 20 – 40
Age above 40
Cervical Cancer Diagnostic Tests Market by Geography
North America
U.S
Europe
Germany
U.K
France
Italy
Spain
R.O.E (Rest of Europe)
Asia Pacific
Japan
China
India
TABLE OF CONTENTS
CHAPTER 1 PREFACE
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
CHAPTER 2 EXECUTIVE SUMMARY AND MARKET OVERVIEW
CHAPTER 3 CERVICAL CANCER DIAGNOSTIC TESTS MARKET ANALYSIS
3.1 MARKET TREND ANALYSIS BY TEST TYPES (USD THOUSANDS)
3.2 MARKET ATTRACTIVENESS – CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY GEOGRAPHY
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 High Prevalence of HPV Infected Patients
3.3.1.2 Rising Number of Female Smokers
3.3.1.3 Rising Incidences of Teenage Sexual Encounters
3.3.1.4 Rising obesity
3.3.1.5 Increased Cancer Awareness Programs
3.3.1.6 Rising Disposable Income of the Consumers
3.3.2 CERVICAL CANCER DIAGNOSTIC TESTS MARKET DRIVER IMPACT ANALYSIS
3.3.3 RESTRAINTS
3.3.3.1 Government Regulations and Guidelines
3.3.3.2 Alternative Cervical Cancer Diagnosis Method
3.3.3.3 Lack of Appropriate Healthcare Infrastructure in Underdeveloped and Developing Countries
3.3.3.4 HPV Vaccination
3.3.3.5 Inaccuracy in Pap Smear Test Results
3.3.4 CERVICAL CANCER DIAGNOSTIC TESTS MARKET RESTRAINTS IMPACT ANALYSIS
3.3.5 OPPORTUNITY
3.3.5.1 Technological advancements
3.3.5.1.1 Technological advancements such as the invention of LBC(Liquid Based Cytology)
3.3.5.2 Aging Global Population Especially in Europe, Japan and the U.S.
3.3.5.3 Healthcare related developments in emerging economies
3.3.6 OPPORTUNITY IMPACT ANALYSIS FOR THE CERVICAL CANCER DIAGNOSTIC TESTS MARKET
3.4 MARKET SHARE BY KEY PLAYERS
3.5 PORTER'S FIVE FORCES ANALYSIS FOR THE CERVICAL CANCER DIAGNOSTIC TESTS MARKET
CHAPTER 4 CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY TEST TYPES
4.1 CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY TEST TYPES – INTRODUCTION
4.2 PAP SMEAR TESTS MARKET
4.2.1 GLOBAL - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
4.2.2 GLOBAL - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
4.2.3 GLOBAL - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
4.3 COLPOSCOPY TESTS MARKET
4.3.1 GLOBAL - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
4.3.2 GLOBAL - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
4.3.3 GLOBAL - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
4.4 ECC PROCEDURE MARKET
4.4.1 GLOBAL - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
4.4.2 GLOBAL – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
CHAPTER 5 CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY GEOGRAPHY
5.1 OVERVIEW
5.2 U.S..
5.2.1 U.S. PAP SMEAR TESTS MARKET
5.2.2 U.S. - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
5.2.3 U.S. - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
5.2.4 U.S. - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
5.2.5 U.S. COLPOSCOPY TESTS MARKET
5.2.6 U.S. - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
5.2.7 U.S. - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
5.2.8 U.S. - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
5.2.9 U.S. ECC PROCEDURE MARKET
5.2.10 U.S. - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
5.2.11 U.S. – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
5.3 EUROPE
5.3.1 MARKET ANALYSIS FOR THE EUROPEAN PAP SMEAR TESTS MARKET
5.3.1.1 Drivers
5.3.1.1.1 European guidelines for quality assurance in cervical cancer diagnosis
5.3.1.2 Restraints
5.3.1.3 Opportunities
5.3.2 U.K
5.3.2.1 U.K Pap Smear Tests Market
5.3.2.2 U.K - Pap smear market by age group, 2012 – 2018 (USD thousands)
5.3.2.3 U.K - number of Pap smear tests performed, 2012 – 2018 (thousands)
5.3.2.4 U.K - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
5.3.2.5 U.K Colposcopy Tests Market
5.3.2.6 U.K - Colposcopy market by age group, 2012 – 2018 (USD thousands)
5.3.2.7 U.K - number of Colposcopy tests performed, 2012 – 2018 (thousands)
5.3.2.8 U.K - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
5.3.2.9 U.K ECC Procedure Market
5.3.2.10 U.K - ECC procedure market by age group, 2012 – 2018 (USD thousands)
5.3.2.11 U.K – number of ECC procedures performed, 2012 – 2018 (thousands)
5.3.3 FRANCE
5.3.3.1 France Pap Smear Tests Market
5.3.3.2 France – Pap smear market by age group, 2012 – 2018 (USD thousands)
5.3.3.3 France - number of Pap smear tests performed, 2012 – 2018 (thousands)
5.3.3.4 France - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
5.3.3.5 France Colposcopy Tests Market
5.3.3.6 France - Colposcopy market by age group, 2012 – 2018 (USD thousands)
5.3.3.7 France - number of Colposcopy tests performed, 2012 – 2018 (thousands)
5.3.3.8 France - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
5.3.3.9 France ECC Procedure Market
5.3.3.10 France - ECC procedure market by age group, 2012 – 2018 (USD thousands)
5.3.3.11 France – number of ECC procedures performed, 2012 – 2018 (thousands)
5.3.4 GERMANY
5.3.4.1 Germany Pap Smear Tests Market
5.3.4.2 Germany - Pap smear market by age group, 2012 – 2018 (USD thousands)
5.3.4.3 Germany - number of Pap smear tests performed, 2012 – 2018 (thousands)
5.3.4.4 Germany - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
5.3.4.5 Germany Colposcopy Tests Market
5.3.4.6 Germany - Colposcopy market by age group, 2012 – 2018 (USD thousands)
5.3.4.7 Germany - number of Colposcopy tests performed, 2012 – 2018 (thousands)
5.3.4.8 Germany - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
5.3.4.9 Germany ECC Procedure Market
5.3.4.10 Germany - ECC procedure market by age group, 2012 – 2018 (USD thousands)
5.3.4.11 Germany – number of ECC procedures performed, 2012 – 2018 (thousands)
5.3.5 ITALY
5.3.5.1 Italy Pap Smear Tests Market
5.3.5.2 Italy - Pap smear market by age group, 2012 – 2018 (USD thousands)
5.3.5.3 Italy - number of Pap smear tests performed, 2012 – 2018 (thousands)
5.3.5.4 Italy - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
5.3.5.5 Italy Colposcopy Tests Market
5.3.5.6 Italy - Colposcopy market by age group, 2012 – 2018 (USD thousands)
5.3.5.7 Italy - number of Colposcopy tests performed, 2012 – 2018 (thousands)
5.3.5.8 Italy - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
5.3.5.9 Italy ECC Procedure Market
5.3.5.10 Italy - ECC procedure market by age group, 2012 – 2018 (USD thousands)
5.3.5.11 Italy – number of ECC procedures performed, 2012 – 2018 (thousands)
5.3.6 SPAIN
5.3.6.1 Spain Pap Smear Tests Market
5.3.6.2 Spain - Pap smear market by age group, 2012 – 2018 (USD thousands)
5.3.6.3 Spain - number of Pap smear tests performed, 2012 – 2018 (thousands)
5.3.6.4 Spain - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
5.3.6.5 Spain Colposcopy Tests Market
5.3.6.6 Spain - Colposcopy market by age group, 2012 – 2018 (USD thousands)
5.3.6.7 Spain - number of Colposcopy tests performed, 2012 – 2018 (thousands)
5.3.6.8 Spain - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
5.3.6.9 Spain ECC Procedure Market
5.3.6.10 Spain - ECC procedure market by age group, 2012 – 2018 (USD thousands)
5.3.6.11 Spain – number of ECC procedures performed, 2012 – 2018 (thousands)
5.3.7 R.O.E
5.3.7.1 R.O.E Pap Smear Tests Market
5.3.7.2 R.O.E - Pap smear market by age group, 2012 – 2018 (USD thousands)
5.3.7.3 R.O.E - number of Pap smear tests performed, 2012 – 2018 (thousands)
5.3.7.4 R.O.E - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
5.3.7.5 R.O.E Colposcopy Tests Market
5.3.7.6 R.O.E - Colposcopy market by age group, 2012 – 2018 (USD thousands)
5.3.7.7 R.O.E - number of Colposcopy tests performed, 2012 – 2018 (thousands)
5.3.7.8 R.O.E - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
5.3.7.9 R.O.E ECC Procedure Market
5.3.7.10 R.O.E - ECC procedure market by age group, 2012 – 2018 (USD thousands)
5.3.7.11 R.O.E – number of ECC procedures performed, 2012 – 2018 (thousands)
5.4 ASIA PACIFIC
5.4.1 JAPAN
5.4.1.1 Japan Pap Smear Tests Market
5.4.1.2 Japan - Pap smear market by age group, 2012 – 2018 (USD thousands)
5.4.1.3 Japan - number of Pap smear tests performed, 2012 – 2018 (thousands)
5.4.1.4 Japan - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
5.4.1.5 Japan Colposcopy Tests Market
5.4.1.6 Japan - Colposcopy market by age group, 2012 – 2018 (USD thousands)
5.4.1.7 Japan - number of Colposcopy tests performed, 2012 – 2018 (thousands)
5.4.1.8 Japan - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
5.4.1.9 Japan ECC Procedure Market
5.4.1.10 Japan - ECC procedure market by age group, 2012 – 2018 (USD thousands)
5.4.1.11 Japan – number of ECC procedures performed, 2012 – 2018 (thousands)
5.4.2 INDIA
5.4.2.1 India Pap Smear Tests Market
5.4.2.2 India - Pap smear market by age group, 2012 – 2018 (USD thousands)
5.4.2.3 India - number of Pap smear tests performed, 2012 – 2018 (thousands)
5.4.2.4 India - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
5.4.2.5 India Colposcopy Tests Market
5.4.2.6 India - Colposcopy market by age group, 2012 – 2018 (USD thousands)
5.4.2.7 India - number of Colposcopy tests performed, 2012 – 2018 (thousands)
5.4.2.8 India - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
5.4.2.9 India ECC Procedure Market
5.4.2.10 India - ECC procedure market by age group, 2012 – 2018 (USD thousands)
5.4.2.11 India – number of ECC procedures performed, 2012 – 2018 (thousands)
5.4.3 CHINA
5.4.3.1 China Pap Smear Tests Market
5.4.3.2 China - Pap smear market by age group, 2012 – 2018 (USD thousands)
5.4.3.3 China - number of Pap smear tests performed, 2012 – 2018 (thousands)
5.4.3.4 China - number of abnormal Pap smear test results, 2012 – 2018 (thousands)
5.4.3.5 China Colposcopy Tests Market
5.4.3.6 China - Colposcopy market by age group, 2012 – 2018 (USD thousands)
5.4.3.7 China - number of Colposcopy tests performed, 2012 – 2018 (thousands)
5.4.3.8 China - number of abnormal Colposcopy procedure test results, 2012 – 2018 (thousands)
5.4.3.9 China ECC Procedure Market
5.4.3.10 China - ECC procedure market by age group, 2012 – 2018 (USD thousands)
5.4.3.11 China – number of ECC procedures performed, 2012 – 2018 (thousands)
CHAPTER 6 COMPANY PROFILES
6.1 GUIDED THERAPEUTICS
6.1.1 COMPANY OVERVIEW
6.1.2 FINANCIAL OVERVIEW
6.1.3 BUSINESS STRATEGIES
6.1.4 PRODUCT PORTFOLIO
6.1.5 RECENT DEVELOPMENTS
6.2 ABOTT LABORATORIES
6.2.1 COMPANY OVERVIEW
6.2.2 FINANCIAL OVERVIEW
6.2.3 BUSINESS STRATEGIES
6.2.4 PRODUCT PORTFOLIO
6.2.5 RECENT DEVELOPMENTS
6.3 BECKMAN COULTER INC.
6.3.1 COMPANY OVERVIEW
6.3.2 FINANCIAL OVERVIEW
6.3.3 BUSINESS STRATEGIES
6.3.4 RECENT DEVELOPMENTS
6.4 BECTON, DICKINSON AND COMPANY
6.4.1 COMPANY OVERVIEW
6.4.2 FINANCIAL OVERVIEW
6.4.3 BUSINESS STRATEGIES
6.4.4 PRODUCT PORTFOLIO
6.5 SIEMENS HEALTHCARE
6.5.1 COMPANY OVERVIEW
6.5.2 FINANCIAL OVERVIEW
6.5.3 BUSINESS STRATEGIES
6.5.4 PRODUCT PORTFOLIO
6.6 BECMAN COULTER INC.
6.6.1 COMPANY OVERVIEW
6.6.2 FINANCIAL OVERVIEW
6.6.3 BUSINESS STRATEGIES
6.6.4 PRODUCT PORTFOLIO
6.7 ASCON MEDICAL INSTRUMENTS
6.7.1 COMPANY OVERVIEW
6.7.2 FINANCIAL OVERVIEW
6.7.3 BUSINESS STRATEGIES
6.7.4 PRODUCT PORTFOLIO
6.7 OLYMPUS
6.8.1 COMPANY OVERVIEW
6.8.2 FINANCIAL OVERVIEW
6.8.3 BUSINESS STRATEGIES
6.8.4 PRODUCT PORTFOLIO
6.9 CARDINAL HEALTH
6.9.1 COMPANY OVERVIEW
6.9.2 FINANCIAL OVERVIEW
6.9.3 BUSINESS STRATEGIES
6.9.4 PRODUCT PORTFOLIO
6.10 ROCHE
6.10.1 COMPANY OVERVIEW
6.10.2 FINANCIAL OVERVIEW
6.10.3 BUSINESS STRATEGIES
6.10.4 PRODUCT PORTFOLIO
LIST OF FIGURES
FIG. 1 MARKET TREND ANALYSIS BY TEST TYPES, 2012 – 2018 (USD THOUSANDS)
FIG. 2 MARKET ATTRACTIVENESS – CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY GEOGRAPHY
FIG. 3 OPPORTUNITY IMPACT ANALYSIS FOR THE CERVICAL CANCER DIAGNOSTIC TESTS MARKET
FIG. 4 PORTER'S FIVE FORCES ANALYSIS FOR THE CERVICAL CANCER DIAGNOSTIC TESTS MARKET
FIG. 5 CERVICAL CANCER DIAGNOSTIC TESTS MARKET BY STEPS
FIG. 6 GLOBAL PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 7 GLOBAL COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 8 GLOBAL ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 9 CERVICAL CANCER DEATHS BY ECONOMY, 2011 (%)
FIG. 10 U.S. PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 11 U.S. COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 12 U.S. ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 13 QUALITY ASSURANCE SYSTEM FOR CERVICAL CANCER DIAGNOSIS, EUROPE
FIG. 14 U.K PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 15 U.K COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 16 U.K ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 17 FRANCE PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 18 FRANCE COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 19 FRANCE ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 20 GERMANY PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 21 GERMANY COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 22 GERMANY ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 23 ITALY PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 24 ITALY COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 25 ITALY ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 26 SPAIN PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 27 SPAIN COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 28 SPAIN ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 29 R.O.E PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 30 R.O.E COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 31 R.O.E ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 32 JAPAN PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 33 JAPAN COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 34 JAPAN ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 35 INDIA PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 36 INDIA COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 37 INDIA ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 38 CHINA PAP SMEAR MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 39 CHINA COLPOSCOPY MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 40 CHINA ECC PROCEDURE MARKET, 2012 – 2018 (USD THOUSANDS)
FIG. 41 GUIDED THERAPEUTICS ANNUAL REVENUE, 2010 – 2011 (USD MILLION)
FIG. 42 BUSINESS STRATEGY CYCLE FOR GUIDED THERAPEUTICS INC.
FIG. 43 ABOTT LABORATORIES ANNUAL REVENUE (USD MILLION), ANNUAL GROWTH RATE (%) 2009 – 2011
FIG. 44 ANNUAL REVENUE, 2008 – 2009 (USD MILLION)
FIG. 45 BECTON, DICKINSON AND COMPANYANNUAL REVENUE (USD MILLION), ANNUAL GROWTH RATE (%) 2007 – 2011
LIST OF TABLES
TABLE 1 IMPACT ANALYSIS OF DRIVERS
TABLE 2 IMPACT ANALYSIS OF RESTRAINTS
TABLE 3 GLOBAL - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 4 GLOBAL - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 5 GLOBAL - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 6 GLOBAL - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 7 GLOBAL - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 8 GLOBAL - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 9 GLOBAL - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 10 GLOBAL – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 11 U.S. - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 12 U.S. - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 13 U.S. - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 14 U.S. - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 15 U.S. - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 16 U.S. - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 17 U.S. - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 18 U.S. – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 19 U.K - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 20 U.K - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 21 U.K - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 22 U.K - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 23 U.K - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 24 U.K - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 25 U.K - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 26 U.K – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 27 FRANCE - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 28 FRANCE - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 29 FRANCE - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 30 FRANCE - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 31 FRANCE - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 32 FRANCE - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 33 FRANCE - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 34 FRANCE – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 35 GERMANY - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 36 GERMANY - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 37 GERMANY - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 38 GERMANY - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 39 GERMANY - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 40 GERMANY - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 41 GERMANY - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 42 GERMANY – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 43 ITALY - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 44 ITALY - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 45 ITALY - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 46 ITALY - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 47 ITALY - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 48 ITALY - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 49 ITALY - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 50 ITALY – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 51 SPAIN - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 52 SPAIN - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 53 SPAIN - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 54 SPAIN - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 55 SPAIN - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 56 SPAIN - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 57 SPAIN - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 58 SPAIN – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 59 R.O.E - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 60 R.O.E - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 61 R.O.E - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 62 R.O.E - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 63 R.O.E - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 64 R.O.E - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 65 R.O.E - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 66 R.O.E – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 67 JAPAN - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 68 JAPAN - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 69 JAPAN - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 70 JAPAN - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 71 JAPAN - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 72 JAPAN - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 73 JAPAN - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 74 JAPAN – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 75 INDIA - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 76 INDIA - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 77 INDIA - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 78 INDIA - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 79 INDIA - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 80 INDIA - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 81 INDIA - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 82 INDIA – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 83 CHINA - PAP SMEAR MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 84 CHINA - NUMBER OF PAP SMEAR TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 85 CHINA - NUMBER OF ABNORMAL PAP SMEAR TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 86 CHINA - COLPOSCOPY MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 87 CHINA - NUMBER OF COLPOSCOPY TESTS PERFORMED, 2012 – 2018 (THOUSANDS)
TABLE 88 CHINA - NUMBER OF ABNORMAL COLPOSCOPY PROCEDURE TEST RESULTS, 2012 – 2018 (THOUSANDS)
TABLE 89 CHINA - ECC PROCEDURE MARKET BY AGE GROUP, 2012 – 2018 (USD THOUSANDS)
TABLE 90 CHINA – NUMBER OF ECC PROCEDURES PERFORMED, 2012 – 2018 (THOUSANDS)
To order this report:
In_Vitro_Diagnostic Industry: Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy And Ecc Procedures) Market - Global Industry Analysis By Test Type And Age Group, Market Size, Share And Forecast, 2012 - 2018
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article